CSL, AU000000CSL8

Citi keeps AUD 180.00 target for CSL stock after FY26 results

Published on 10/26/2026 at 16:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Morgan Stanley kept its AUD 200.00 target on October 22, 2026. CSL stock costs EUR 122.39 on October 26, 2026 at Lang & Schwarz.

Analyst target and company dates

  • Citi set an AUD 180.00 target for CSL on October 25, 2026.
  • Fiscal year 2026 revenue reached USD 15.797 billion, while underlying NPATA fell 4 percent.
  • CSL stock costs EUR 122.39 at Lang & Schwarz on October 26, 2026 at 4:04 p.m. CEST.
  • CSL will hold its annual meeting on October 27, 2026.
CSL, AU000000CSL8, Illustration mit AI erstellt.

CSL (AU000000CSL8) is facing a fresh analyst reference after Citi maintained a Hold rating and set an AUD 180.00 price target on October 25, 2026, according to Markets Insider. CSL stock was trading at EUR 122.39 at Lang & Schwarz on October 26, 2026 at 4:04 p.m. CEST.

Fiscal year 2026 results explain why analysts remain divided. Revenue reached USD 15.797 billion for the year ended June 30, 2026, up 2 percent on a reported-currency basis, while underlying net profit after tax before amortization fell 4 percent to USD 3.098 billion, Business News Today reported on October 25, 2026.

Analysts split on AUD 180.00 to AUD 200.00

Citi's AUD 180.00 target contrasts with Morgan Stanley's AUD 200.00 target, which the firm maintained on October 22, 2026, according to Markets Insider. The difference places the two published targets AUD 20.00 apart and leaves the recovery case dependent on improved operating execution rather than a single broker view.

What dates matter for CSL?

CSL's annual general meeting is scheduled for October 27, 2026, at the company's Melbourne venue and online, according to the CSL investor relations page. A separate market report lists February 10, 2027 as the expected date for the half-year results, giving investors a second dated checkpoint for the recovery plan.

CSL stock stays in a wide frame

The ASX-listed company had a market capitalization of AUD 93.6 billion as of October 26, 2026. Its 52-week range was AUD 90.00 to AUD 213.85, putting the latest ASX price of AUD 195.14 within the upper part of that span at the latest quoted time.

Price and dates for investors

The immediate calendar is unusually tight: the annual meeting falls on October 27, 2026, while the February 10, 2027 reporting date gives the next major operating milestone. The analyst spread from AUD 180.00 to AUD 200.00 shows how differently the recovery outlook is being valued.

The further course of trading is shown by the continuously updated real-time quote of CSL stock.

CSL stock at a glance

  • Company: CSL Limited
  • ISIN: AU000000CSL8
  • Ticker: CSL
  • Primary exchange: ASX
  • Price Lang & Schwarz (as of October 26, 2026, 4:04 p.m. CEST): EUR 122.39
  • Market capitalization: AUD 93.6 billion (as of October 26, 2026)
  • 52-week range: AUD 90.00-213.85 (as of October 26, 2026)
  • Sector / Industry: Healthcare / Biotechnology

Market context: Market report S&P/ASX 200.

More news and analyses on CSL stock

Disclaimer...
en | AU000000CSL8 | CSL | boerse | 70415300 |